Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00872131 · ClinicalTrials.gov registry record
Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 200
- Enrollment target
NCT00872131: Completed study, sponsored by University of Michigan.
NCT00872131 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00872131 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This study will attempt to identify gene and brain activity markers that predict whether people with social anxiety disorder will respond to selective serotonin reuptake inhibitor medications.
Interventions
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-08 |
What the finished NCT00872131 record still lists
NCT00872131 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Sertraline is the first listed.
NCT00872131 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00872131 about?
NCT00872131 is a clinical study titled "Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder". This study will attempt to identify gene and brain activity markers that predict whether people with social anxiety disorder will respond to selective serotonin reuptake inhibitor medications.
What is the current status of trial NCT00872131?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2008-03. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00872131?
The interventions under investigation include: Sertraline (DRUG).
Who is sponsoring clinical trial NCT00872131?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia